Ravaggi, A.; Capoferri, D.; Ardighieri, L.; Ghini, I.; Ferrari, F.; Romani, C.; Bugatti, M.; Zanotti, L.; Vrede, S.; Tognon, G.;
et al. Integrated Biomarker Analysis Reveals L1CAM as a Potential Stratification Marker for No Specific Molecular Profile High-Risk Endometrial Carcinoma. Cancers 2022, 14, 5429.
https://doi.org/10.3390/cancers14215429
AMA Style
Ravaggi A, Capoferri D, Ardighieri L, Ghini I, Ferrari F, Romani C, Bugatti M, Zanotti L, Vrede S, Tognon G,
et al. Integrated Biomarker Analysis Reveals L1CAM as a Potential Stratification Marker for No Specific Molecular Profile High-Risk Endometrial Carcinoma. Cancers. 2022; 14(21):5429.
https://doi.org/10.3390/cancers14215429
Chicago/Turabian Style
Ravaggi, Antonella, Davide Capoferri, Laura Ardighieri, Iacopo Ghini, Federico Ferrari, Chiara Romani, Mattia Bugatti, Laura Zanotti, Stephanie Vrede, Germana Tognon,
and et al. 2022. "Integrated Biomarker Analysis Reveals L1CAM as a Potential Stratification Marker for No Specific Molecular Profile High-Risk Endometrial Carcinoma" Cancers 14, no. 21: 5429.
https://doi.org/10.3390/cancers14215429
APA Style
Ravaggi, A., Capoferri, D., Ardighieri, L., Ghini, I., Ferrari, F., Romani, C., Bugatti, M., Zanotti, L., Vrede, S., Tognon, G., Pijnenborg, J. M. A., Sartori, E., Calza, S., Bignotti, E., & Odicino, F.
(2022). Integrated Biomarker Analysis Reveals L1CAM as a Potential Stratification Marker for No Specific Molecular Profile High-Risk Endometrial Carcinoma. Cancers, 14(21), 5429.
https://doi.org/10.3390/cancers14215429